Stockreport

A $4.8 Billion Reason to Buy BioMarin Stock Today [Yahoo! Finance]

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com
PDF The all-cash transaction values each FOLD share at $14.50, a 33% premium over their previous close, indicating BioMarin's commitment to expanding its footprint in the r [Read more]